AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

VANCOUVER, British Columbia--(BUSINESS WIRE)-- $ABCL -- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera’s Investor Relations website . A replay will be available through the same link following the presentation. About AbCellera Biologics Inc . AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com . Contacts Inquiries Media: Tiffany Chiu; media@abcellera.com , +1(236)521-6774 Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com , +1(604)559-9005 Investor Relations: Peter Ahn; ir@abcellera.com , +1(778)729-9116